ADMA Biologics Inc (ADMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
27 Pages - GLDATA62663
$250.00

Summary

ADMA Biologics Inc (ADMA Biologics) is a late stage biopharmaceutical company that develops, manufactures and markets specialty plasma-based biologics for the treatment and prevention of certain infectious diseases. The company’s lead product candidate RI-002, is a specialty plasma-derived, polyclonal, Intravenous Immune Globulin (IGIV), derived from human plasma containing naturally occurring polyclonal antibodies. ADMA Biologics’ target treatment areas include bacterial infections, respiratory syncytial virus and primary immune deficiency diseases (PIDD). The company has contract manufacturing relationship with Biotest Pharmaceuticals. It also operates ADMA BioCenters, FDA-licensed source plasma collection facilities which provide a portion of blood plasma for the manufacturing of its product RI-002. ADMA Biologics is headquartered in Ramsey, New Jersey, the US.

ADMA Biologics Inc (ADMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ADMA Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
ADMA Biologics to Acquire Certain Assets from Biotest Pharma 10
Venture Financing 11
ADMA Biologics to Secure USD21 Million from Oxford Finance 11
Adma Biologics Secures USD5 Million from Hercules 12
ADMA Biologics Secures Venture Funding from Biomark Capital 13
ADMA Plasma Biologics Raises US$17.6 Million In Venture Financing 14
Licensing Agreements 15
Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 15
Adma Biologics Enters Into Licensing Agreement With Biotest For IGIV 16
Adma Biologics Enters Into Licensing Agreement With Biotest For Varicella Zoster Immune Globulin 16
Equity Offering 17
ADMA Biologics Raises USD14 Million in Public Offering of Shares 17
ADMA Biologics Raises USD11.2 Million in Public Offering of Shares 19
ADMA Biologics Completes IPO For US$28.5 Million 20
ADMA Biologics Completes Private Placement Of Shares For US$17.6 Million 21
Acquisition 23
R&R Acquisition Acquires ADMA Biologics In Reverse Acquisition 23
ADMA Biologics Inc - Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ADMA Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ADMA Biologics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ADMA Biologics to Acquire Certain Assets from Biotest Pharma 10
ADMA Biologics to Secure USD21 Million from Oxford Finance 11
Adma Biologics Secures USD5 Million from Hercules 12
ADMA Biologics Secures Venture Funding from Biomark Capital 13
ADMA Plasma Biologics Raises US$17.6 Million In Venture Financing 14
Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 15
Adma Biologics Enters Into Licensing Agreement With Biotest For IGIV 16
Adma Biologics Enters Into Licensing Agreement With Biotest For Varicella Zoster Immune Globulin 16
ADMA Biologics Raises USD14 Million in Public Offering of Shares 17
ADMA Biologics Raises USD11.2 Million in Public Offering of Shares 19
ADMA Biologics Completes IPO For US$28.5 Million 20
ADMA Biologics Completes Private Placement Of Shares For US$17.6 Million 21
R&R Acquisition Acquires ADMA Biologics In Reverse Acquisition 23
ADMA Biologics Inc, Key Competitors 24
ADMA Biologics Inc, Key Employees 25
ADMA Biologics Inc, Subsidiaries 26

List of Figures
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838